Arnau Serra-Abella
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
PSA Response as a Prognostic Marker in Metastatic Hormone-sensitive Prostate Cancer: Comparison with Tumor Volume (CHAARTED).
Journal: European urology open science
Published: May 01, 2026
Effectiveness and safety of hormonal doublet therapy in metastatic hormone-sensitive prostate cancer: A multicenter real-world study.
Journal: Actas urologicas espanolas
Published: March 03, 2026
Clinical Variable-Based Machine Learning for Predicting Early mCRPC Using Exclusively Clinical Variables: Development and Multicenter External Validation.
Journal: The Prostate
Published: January 31, 2026
PSA response to predict progression in metastatic hormone-sensitive prostate cancer (mHSPC) patients. When is the optimal time point?
Journal: Urologic oncology
Published: May 06, 2025
PSA kinetics and predictors of PSA response in metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors.
Journal: Urologic oncology
Published: February 13, 2025
Multicenter study of active surveillance for small renal masses: Real world practice pattern.
Journal: Urologic oncology
Published: November 06, 2024
Initial results of the implementation of an ambulatory mini percutaneous nephrolithotomy program.
Journal: Actas urologicas espanolas
Published: February 01, 2023
Preliminary results of the implementation of robotic radical prostatectomy in a major ambulatory surgery regimen.
Journal: Actas urologicas espanolas
Published: February 15, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026